A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
Completed
Boehringer Ingelheim
Phase 3
2002-06-01
A 12-week trial consisting of 5 visits (6 if follow up is needed) to find out how effective
and safe three different doses of meloxicam are compared with placebo in Rheumatoid
Arthritis. Patient will take one dose of study medication daily.
Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy
Completed
Princess Margaret Hospital, Canada
Phase 3
2004-02-01
Swelling of the prostate can occur during and after a brachytherapy. This swelling can cause
urinary problems ranging from difficulty voiding to urinary retention. The purpose of this
study is to investigate whether Mobicox started one week before brachytherapy and then
continued afterwards is more effective in reducing the risk of needing a catheter than
Mobicox given only afterwards.
Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy
Completed
University Health Network, Toronto
Phase 3
2004-02-01
Swelling of the prostate can occur during and after a brachytherapy. This swelling can cause
urinary problems ranging from difficulty voiding to urinary retention. The purpose of this
study is to investigate whether Mobicox started one week before brachytherapy and then
continued afterwards is more effective in reducing the risk of needing a catheter than
Mobicox given only afterwards.
A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis
Completed
Boehringer Ingelheim
Phase 3
2004-07-01
The objective of this trial was to assess the efficacy and safety of 15 mg meloxicam i.m.
once daily compared with 15 mg meloxicam tablets once daily p.o. in patients with Rheumatoid
arthritis over a time period of 7 days.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
